Android app Apple app link

Allink Biotherapeutics secures funding to advance ADC pipeline

By Yahoo! Finance   |   1 year ago
Allink Biotherapeutics secures funding to advance ADC pipeline

Allink Biotherapeutics has raised $42m in Series A funding to accelerate the global development of its bispecific antibody and antibody-drug conjugate pipeline. The funding will support the clinical development of lead candidates and the enrichment of its oncology and immunology portfolio.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.